同期杂交冠状动脉血运重建对术后出血和肾功能的影响:与微创直视非体外循环冠状动脉旁路移植术在多支冠状动脉病变患者中的对比研究
该回顾性研究比较了多支冠状动脉病变患者接受同期杂交冠状动脉血运重建(HCR)与微创直视非体外循环冠状动脉旁路移植术(MIDCABG)后的出血和肾功能变化。倾向性评分匹配后纳入317对患者,同期HCR组手术当日胸腔引流量显著多于MIDCABG组,但术后总引流量、再探查止血、输血、急性肾损伤及院内主要不良心脑血管事件两组差异均无统计学意义。结论认为同期HCR(先MIDCABG,即刻PCI)不增加术后出血或急性肾损伤发生率。
要点
- 同期HCR组手术当日胸腔引流量显著高于MIDCABG组(492.7±282.4 mL vs 441.0±261.9 mL,P=.023)。
- 术后总引流量两组差异无统计学意义(788.8±458.9 mL vs 753.3±409.8 mL,P=.74)。
- 再探查止血、输血、急性肾损伤及院内MACCE发生率两组差异均无统计学意义。
核心结论
- 与MIDCABG相比,同期HCR(先MIDCABG,即刻经皮冠状动脉介入治疗)不增加术后出血或急性肾损伤发生率。
研究设计与样本
- 回顾性收集2007年6月至2020年12月阜外医院594例同期HCR和351例MIDCABG(计划分期HCR,先MIDCABG后择期PCI)连续患者的数据。
- 采用倾向性评分匹配按1:1比例纳入317对患者,比较两组出血和肾功能变化。
主要发现
- 同期HCR组手术当日胸腔引流量大于MIDCABG组(492.7±282.4 mL vs 441.0±261.9 mL,P=.023)。
- 术后总引流量两组差异无统计学意义(788.8±458.9 mL vs 753.3±409.8 mL,P=.74)。
- 再探查止血两组差异无统计学意义(0.3% vs 1.6%,P=.13)。
- 输血两组差异无统计学意义(18.9% vs 16.4%,P=.13)。
- 急性肾损伤两组差异无统计学意义(23.3% vs 18.6%,P=.53)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The present study sought to compare postoperative bleeding and renal function in patients with multivessel coronary artery disease undergoing simultaneous hybrid coronary revascularization (HCR) and minimally invasive direct off-pump coronary artery bypass grafting (MIDCABG). METHODS: The study retrospectively collected the data of 594 consecutive patients who underwent simultaneous HCR and 351 patients who underwent MIDCABG with planned staged HCR (MIDCABG first, then elective percutaneous coronary intervention) in Fuwai Hospital from June 2007 to December 2020. A total of 317 pairs of patients who were matched in a 1:1 ratio with propensity score matching were enrolled in this study. Bleeding and changes in renal function were compared between the 2 groups. RESULTS: Compared with patients who underwent MIDCABG, patients who underwent simultaneous HCR had significantly greater chest tube drainage on the day of the operation (492.7 ± 282.4 mL vs 441.0 ± 261.9 mL; P = .023), but no significant difference was detected in the total amount during the postoperative period (788.8 ± 458.9 mL vs 753.3 ± 409.8 mL; P = .74). The differences in re-exploration for bleeding (0.3% vs 1.6%; P = .13), blood transfusion (18.9% vs 16.4%; P = .13), acute kidney injury (23.3% vs 18.6%; P = .53), and in-hospital major adverse cardiovascular and cerebrovascular events (including all-cause death, myocardial infarction, stroke, and repeated revascularization) (2.5% vs 1.9%; P = .67) between the 2 groups did not reach statistical significance. CONCLUSIONS: Compared with MIDCABG, simultaneous HCR (MIDCABG first, instant percutaneous coronary intervention) did not increase postoperative bleeding or the incidence of acute kidney injury.
引用
- Ding T, Hu S, Qu J, et al. Evaluation of the effect of simultaneous hybrid coronary revascularization on postoperative bleeding and renal function: A comparison study with minimally invasive direct off-pump coronary artery bypass grafting in patients with multivessel coronary artery disease. J Thorac Cardiovasc Surg. 2022. PMID: 35272844. doi:10.1016/j.jtcvs.2022.01.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。